The enzymes in human cells known as histone deacetylases, or HDACs, are targets for a handful of anticancer drugs because of their ability to affect gene expression. Now, researchers have developed a new method to investigate how these enzymes work on a molecular level. This new method can also help identify more precise possible anti-cancer drug candidates at a very high pace.

More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a new statement.

A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury.

A world-first discovery could become a game-changer for patients at risk of rapid health deterioration, such as heart complications, stroke, sepsis and cancer. Researchers developed an antibody as a biosensor, to continuously monitor rapid changes in the concentration of EGFR, a protein present on cancer cells and in body fluids.

Neal Crabtree, a welding foreman who began working on pipeline construction as an apprentice in 1997, was dismayed when he heard the news. 

Researchers have tested a new combination therapy in animal models to see if they could find a way to make an already effective treatment even better. Since they're using a Food and Drug Administration-approved drug to do it, this could help people sooner than later.

Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial.

Janice Johnston had 18 months of needless chemotherapy, causing her numerous physical problems.

Nobody will be immune or exempt from the cancel culture mob as long as the media continues to wield it as a weapon to silence their critics and limit free speech, investigative journalist Glenn Greenwald warned over the weekend.

A team of legal experts is set to file the first cases against the NATO alliance on behalf of people who developed cancer after being exposed to depleted uranium munitions during the Serbian bombings in 1999. The first lawsuit is expected to be filed before the Higher Court in Belgrade on Wednesday, following years of extensive work by a team of legal experts led by lawyer Srdjan Aleksic. Dozens of other lawsuits will be filed before other courts across the country as well. The team is seeking to win compensation of at...